On ECHEMI
Home > Drugs > Chlorphenamine yellow sensitive tablets

Chlorphenamine yellow sensitive tablets

Function and Efficacy

According to literature reports: Diclofenac sodium in this product is a non-steroidal anti-inflammatory analgesic derived from phenylacetic acid. Its mechanism of action is to inhibit the activity of cyclooxygenase, thereby blocking the conversion of arachidonic acid to prostaglandins. At the same time, it can also promote the combination of arachidonic acid and triglycerides, reduce the concentration of free arachidonic acid in cells, and indirectly inhibit the synthesis of leukotrienes. Diclofenac sodium is a stronger non-steroidal anti-inflammatory drug. Its inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin. Chlorpheniramine maleate antagonizes the allergic reaction of histamine by antagonizing H1 receptors, does not affect histamine metabolism, does not prevent the release of histamine in the body, and has M choline receptor blocking and central inhibition effects. Artificial bezoar has antipyretic, analgesic, sedative, and anti-inflammatory effects.

Ingredients

This product is a compound preparation, and its components per tablet are: diclofenac sodium 15 mg, artificial bezoar 15 mg, and chlorpheniramine maleate 2.5 mg.

Name Description Content CAS NO. Manufacturer
Diclofenac sodiumIngredients

Inhibits cyclooxygenase activity, thereby blocking the conversion of arachidonic acid to prostaglandins; promotes the combination of arachidonic acid and triglycerides, reduces the concentration of free arachidonic acid in cells, and indirectly inhibits the synthesis of leukotrienes

More
15307-79-6 55
Atificial Cow-bezoarIngredients

Antipyretic, analgesic, sedative, anti-inflammatory

More
1002-00-2 2
Chlorphenamine maleateIngredients

It can counteract the allergic reaction of histamine by antagonizing H1 receptors, does not affect histamine metabolism, does not prevent the release of histamine in the body, and has M cholinergic receptor blocking and central inhibition effects

More
113-92-8 28

Appearance

This product is a film-coated tablet, which is light yellow after removing the coating.

Indication

Used for headache, fever, nasal congestion, runny nose, sore throat, and excessive sputum caused by colds.

Usage and Dosage

Oral administration, 1-2 tablets at a time, 3 times a day or as directed by a physician.

Adverse Reactions

There are many case reports of children suffering from hematuria after taking the medicine; followed by stomach discomfort and burning sensation; in addition, there are also adverse reactions such as headache, dizziness, drowsiness, rash, palpitations, chest tightness, and sore throat.

Precautions

1. It is contraindicated for patients who are allergic to diclofenac sodium, chlorpheniramine maleate and artificial bezoar. 2. It is contraindicated for newborns or premature infants. 3. It is contraindicated for patients with liver and kidney dysfunction.

Special Population Medication

Precautions for children: Not suitable for newborns or premature infants; Use with caution in children. Precautions for pregnancy and lactation: Not suitable for use. Precautions for the elderly: Not clear yet.

Drug Interactions

1. When used with aspirin or other salicylic acid drugs, the efficacy does not increase, but the incidence of gastrointestinal adverse reactions and bleeding tendency increases. 2. This product can reduce the effects of insulin and other hypoglycemic drugs, causing blood sugar to rise. 3. Aspirin can reduce the bioavailability of this product. 4. This product can enhance the effects of amantadine, anticholinergic drugs, phenothiazines, and antisympathomimetic drugs. 5. When this product is taken with tricyclic antidepressants, it can enhance the efficacy of the latter.

Storage

Keep sealed.

Packaging Specification

Diclofenac sodium 15mg, artificial bezoar 15mg, chlorpheniramine maleate 2.5mg

Validity Period

Tentative 24 months

Manufacturer

Shanxi Wanglong Pharmaceutical Group Co., Ltd.

  • Founded in:

    2002-11-30
  • Address:

    Shanxi Province Houma Huinan Industrial Park
  • Tax NO.:

    91141081743536092T
  • Registered Funds:

    60 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.